learn more about company
Lipid Systems Sp. z o.o. is a modern pharmaceutical company, owning the unique, patented technology of active substances efficient closing in liposomal carriers, allowing their effective transport in the body. We have the ability to produce state-of-the-art liposomal formulations of medicines, medical devices and food supplements in international quality standards.
Highly qualified team of Lipid Systems provides the company with dynamic development based on many years of market experience and a wide range of competences, starting from liposome research, through clinical trials, project commercialization up to the sale, marketing and export of our products.
Apart from using our own know-how, we contribute to our projects establishing long-term cooperation with modern research centres around the world.
Lipid Systems is an owner of the innovative liposomal technology LIPOSHELL® (international patent application No. PCT / EP2018 / 057400). The key element of LIPOSHELL® technology are liposomes – precisely designed and manufactured in conditions ensuring high quality, stability and reproducible size.
Close cooperation with the best production engineers enables us to construct technological lines specific to the requirements. We introduce our own innovative production solutions, which increase efficiency as well as allow us to fully control processes, in order to obtain the finished product of the highest quality.
Our company continuously works on novel solutions for efficient drug delivery. As company we successfully publish our results in IF scientific journals. Currently we are working on the following scientific tasks which are financed by our own resources as well as public funds.
“Development of a highly purified form of phospholipids for use in the production of liposome-targeted drug carriers, medical devices and supplements.”
“Innovative nanocarriers of cytostatic in Sonosome® technology for local release using high intensity focused ultrasound (HIFU)”
“siRNA based treatment of psoriasis enhanced by the application of the innovative dermal delivery system“
We would like to invite you to listen to a lecture based on our experience in implementing science into practice.
Classical pharmacology is based on the average — an average patient, average physiological parameters, average drug distribution and average treatment. Such an approach works well in some applications and in terms of drug development cost reduction, but it does not provide sufficient efficiency in many cases. Therefore, in the last few decades novel strategies have been developed which could overcome unspecific drug delivery, such as targeted drug delivery systems among which liposomal formulations are one of the most promising. During the talk practical examples of the development of target drug delivery systems will be presented.
